Xeris Biopharma Ownership | Who Owns Xeris Biopharma?


OverviewForecastRevenueFinancialsChartTranscripts

Xeris Biopharma Ownership Summary


Xeris Biopharma is owned by 36.25% institutional investors, 3.92% insiders, and 59.84% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.65% of XERS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.97% of its assets in Xeris Biopharma shares.

XERS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockXeris Biopharma36.25%3.92%59.84%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de11.93M7.65%$97.09M
Blackrock10.33M7.35%$23.25M
Vanguard group9.83M6.30%$80.00M
Geode capital management4.14M2.65%$33.71M
State street3.74M2.40%$30.43M
Qube research3.27M2.10%$26.66M
Morgan stanley3.22M2.06%$26.21M
Nuveen2.83M1.81%$23.02M
Driehaus capital management2.62M1.68%$21.32M
Millennium management1.95M1.31%$6.61M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Rosalind advisors1.80M5.00%$14.62M
Knott david m jr1.01M3.33%$8.26M
Parkman healthcare partners1.79M1.52%$14.58M
Essex investment management750.03K0.93%$6.11M
Eam investors603.10K0.56%$4.85M
Redmile group451.10K0.36%$3.67M
Semanteon capital management, lp32.92K0.34%$268.01K
Centerbook partners lp698.20K0.28%$5.68M
Kennedy capital management1.21M0.22%$9.86M
Legato capital management216.81K0.19%$1.76M

Top Buyers

HolderShares% AssetsChange
Ubs group1.78M0.00%1.55M
Jane street group913.76K0.00%882.59K
Charles schwab investment management1.45M0.00%879.08K
Deutsche bank ag\1.57M0.00%830.72K
Bnp paribas arbitrage, snc581.72K0.00%565.41K

Top Sellers

HolderShares% AssetsChange
Bioimpact capital---4.83M
Aigh capital management---2.57M
Caxton---2.02M
Centerbook partners lp698.20K0.28%-896.02K
Cubist systematic strategies---880.31K

New Positions

HolderShares% AssetsChangeValue
Divisadero street capital management, lp406.33K0.14%406.33K$3.31M
Canada pension plan investment board375.70K0.00%375.70K$3.06M
Granahan investment management350.17K0.12%350.17K$2.85M
Swiss national bank310.40K0.00%310.40K$2.53M
Trexquant investment lp229.42K0.02%229.42K$1.87M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-27.00
Wealthtrak capital management-40.00
Bryn mawr trust-40.00
American capital advisory-50.00
Stephens consulting-65.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2025137-33.50%56,532,097-37.58%361.07%80-25.23%33-43.10%
Jun 30, 2025205-90,532,2314.30%581.79%106-17.83%5845.00%
Mar 31, 202520424.39%86,739,12632.43%562.94%12946.59%3914.71%
Dec 31, 202468-53.42%28,055,641-56.11%181.02%34-53.42%9-73.53%
Sep 30, 20241434.38%63,815,8025.21%422.30%711.43%34-5.56%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.80M2.97%-106.27K
Vanguard US Total Market Shares ETF4.25M2.76%-
iShares Russell 2000 ETF3.64M2.26%-
Vanguard Institutional Extnd Mkt Idx Tr1.73M1.07%-781.92K
CREF Stock R11.48M0.96%-
Fidelity Small Cap Index1.50M0.93%82.40K
Nuveen Quant Small Cap Equity R61.38M0.85%199.60K
iShares Russell 2000 Growth ETF1.33M0.82%-
CREF Stock R3872.07K0.54%294.50K
Fidelity Extended Market Index867.45K0.54%9.33K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 13, 2025Shannon John Patrick Jr See RemarksSell$173.40K
Nov 11, 2025Hecht Beth See RemarksSell$123.30K
Sep 11, 2025PERSKY MARLA-Sell$119.61K
Aug 28, 2025SHERMAN JEFFREY W-Sell$334.52K
Aug 13, 2025JOHNSON JOHN-Sell$786.46K

Insider Transactions Trends


DateBuySell
2025 Q4-1
2025 Q3-4
2025 Q21-
2025 Q1-1
2024 Q4--

XERS Ownership FAQ


Who Owns Xeris Biopharma?

Xeris Biopharma shareholders are primarily institutional investors at 36.24%, followed by 3.92% insiders and 59.84% retail investors. The average institutional ownership in Xeris Biopharma's industry, Biotech Stocks , is 45.24%, which Xeris Biopharma falls below.

Who owns the most shares of Xeris Biopharma?

Xeris Biopharma’s largest shareholders are Blackrock funding, inc. /de (11.93M shares, 7.65%), Blackrock (10.33M shares, 7.35%), and Vanguard group (9.83M shares, 6.30%). Together, they hold 21.30% of Xeris Biopharma’s total shares outstanding.

Does Blackrock own Xeris Biopharma?

Yes, BlackRock owns 7.35% of Xeris Biopharma, totaling 10.33M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 23.25M$. In the last quarter, BlackRock increased its holdings by 371.57K shares, a 3.73% change.

Who is Xeris Biopharma’s biggest shareholder by percentage of total assets invested?

Rosalind advisors is Xeris Biopharma’s biggest shareholder by percentage of total assets invested, with 5.00% of its assets in 1.8M Xeris Biopharma shares, valued at 14.62M$.

Who is the top mutual fund holder of Xeris Biopharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Xeris Biopharma shares, with 2.97% of its total shares outstanding invested in 4.8M Xeris Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools